MAIN STORY
Financial terms advanced while leadership remained unresolved
The Financial Times account, relayed by Reuters, says Smith & Nephew approached Johnson & Johnson earlier in 2026 about combining with its orthopaedics operation. Discussions had reportedly reached an advanced stage and the participants considered announcing a transaction in mid-October. Yet talks ended weeks before the report emerged. The proposed ownership split gave Johnson & Johnson investors 50.1% of the enlarged company, a narrow majority that did not settle the practical question of executive control.
The disputed candidates were both familiar with the industry. Namal Nawana led Smith & Nephew for roughly 18 months before leaving in 2019 and now heads Johnson & Johnson's orthopaedics division. Deepak Nath is the current Smith & Nephew CEO. People cited by the newspaper said the US group wanted Nawana to run the combination, while Smith & Nephew insisted on Nath. Because the companies have not publicly verified the negotiations, the reported governance terms should not be mistaken for signed or binding commitments.
















